Tower Research Capital LLC (Trc) Vir Biotechnology, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $4.87 Billion
  • Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 61,391 shares of VIR stock, worth $515,070. This represents 0.01% of its overall portfolio holdings.

Number of Shares
61,391
Previous 15,013 308.92%
Holding current value
$515,070
Previous $112,000 301.79%
% of portfolio
0.01%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$6.74 - $10.17 $312,587 - $471,664
46,378 Added 308.92%
61,391 $450,000
Q3 2024

Nov 14, 2024
SELL
$7.26 - $10.7 $36,655 - $54,024
-5,049 Reduced 25.17%
15,013 $112,000
Q2 2024

Aug 13, 2024
BUY
$7.63 - $12.66 $145,588 - $241,565
19,081 Added 1945.06%
20,062 $178,000
Q1 2024

May 15, 2024
SELL
$8.6 - $11.9 $125,284 - $173,359
-14,568 Reduced 93.69%
981 $9,000
Q4 2023

Feb 13, 2024
BUY
$7.76 - $10.29 $87,517 - $116,050
11,278 Added 264.06%
15,549 $156,000
Q3 2023

Nov 14, 2023
SELL
$9.14 - $24.62 $13,737 - $37,003
-1,503 Reduced 26.03%
4,271 $40,000
Q2 2023

Aug 14, 2023
BUY
$23.2 - $27.29 $48,093 - $56,572
2,073 Added 56.01%
5,774 $141,000
Q1 2023

May 09, 2023
SELL
$22.26 - $30.85 $64,375 - $89,218
-2,892 Reduced 43.86%
3,701 $86,000
Q4 2022

Feb 10, 2023
SELL
$19.96 - $28.22 $2,075 - $2,934
-104 Reduced 1.55%
6,593 $167,000
Q3 2022

Nov 10, 2022
SELL
$18.26 - $31.1 $364,743 - $621,222
-19,975 Reduced 74.89%
6,697 $129,000
Q2 2022

Aug 15, 2022
BUY
$19.08 - $26.7 $172,635 - $241,581
9,048 Added 51.34%
26,672 $680,000
Q1 2022

May 12, 2022
BUY
$21.19 - $40.01 $37,357 - $70,537
1,763 Added 11.12%
17,624 $453,000
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $418,311 - $729,783
13,507 Added 573.79%
15,861 $664,000
Q3 2021

Nov 15, 2021
SELL
$34.9 - $54.54 $67,391 - $105,316
-1,931 Reduced 45.06%
2,354 $103,000
Q2 2021

Aug 16, 2021
BUY
$38.75 - $51.0 $75,407 - $99,246
1,946 Added 83.2%
4,285 $202,000
Q1 2021

May 17, 2021
BUY
$26.34 - $83.07 $25,312 - $79,830
961 Added 69.74%
2,339 $120,000
Q4 2020

Feb 16, 2021
SELL
$25.51 - $43.38 $1.11 Million - $1.89 Million
-43,664 Reduced 96.94%
1,378 $37,000
Q3 2020

Nov 16, 2020
BUY
$28.28 - $53.6 $1.17 Million - $2.22 Million
41,351 Added 1120.32%
45,042 $1.55 Million
Q2 2020

Aug 13, 2020
BUY
$27.89 - $47.86 $102,941 - $176,651
3,691 New
3,691 $151,000
Q1 2020

May 15, 2020
SELL
$12.04 - $60.2 $22,972 - $114,861
-1,908 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$11.83 - $15.85 $22,571 - $30,241
1,908 New
1,908 $24,000

Others Institutions Holding VIR

# of Institutions
232
Shares Held
90.1M
Call Options Held
1.28M
Put Options Held
235K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.11B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email